pharma-company /Medicinal products /Active ingredients

Rx · PZN 15657444

ZIRABEV 25 mg/ml 100mg concentrate for preparation of a solution for infusion vial

German trade nameZIRABEV 25 mg-ml 100mg Konzentrat zur Herstellung einer Infusionslösung Durchstechflasche

Active ingredientBevacizumabPharmaceutical formConcentrate for solution for infusion

Only sporadically available

2.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €275

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for ZIRABEV 25 mg/ml 100mg concentrate for preparation of a solution for infusion vial.

Review purchasing terms

ZIRABEV 25 mg/ml 100mg concentrate for preparation of a solution for infusion vial contains the active ingredient Bevacizumab and comes as Concentrate for solution for infusion. One pack size is recorded (PZN 15657444). The pharma availability index for German wholesale stands at 2.6 out of 10 over the past 30 days – the pack was therefore only sporadically available.


ZIRABEV 25 mg/ml 100mg concentrate for preparation of a solution for infusion vial was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.